GUSTO V: the bottom line of fibrinolytic reperfusion therapy.
Verheugt
F W
FW
Division of Cardiology, Heartcenter, University Medical Center St Radboud, 6525, Nijmegen, Netherlands. f.verheugt@cardio.azn.nl
D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D015912:Thrombolytic Therapy; D016896:Treatment Outcome